Chronic kidney disease and dialysis in Mexico

Peritoneal Dialysis International

Volumn 27, Issue 4, 2007, Pages 405-409

  Paniagua, Ramón ^a   Ramos, Alfonso ^b   Fabian, Rosaura ^c   Lagunas, Jesús ^c   Amato, Dante ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Hospital General de Zona 1 Hermosillo   (Mexico)

^c Instituto Mexicano del Seguro Sacial   (Mexico)

Author keywords

Chronic kidney disease; Mexico

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CARBONATE; DIALYSIS FLUID; ERYTHROPOIETIN; IRON;

ANEMIA; ARTICLE; CHILD HEALTH CARE; CHRONIC KIDNEY DISEASE; CLINICAL NURSE SPECIALIST; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH STATISTICS; HUMAN; HYPERTENSION; HYPOPHOSPHATEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEXICO; NEPHROLOGIST; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RESOURCE MANAGEMENT; SOCIAL INSURANCE; SOCIAL SECURITY;

EID: 34547614316     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700406     Document Type: Article

References (24)

1. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365:331-40.
2. Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gomez-Perez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 2005; 36:188-96.
3. Obesidad en México. Encuesta Nacional de Salud; 2006. http://www.insp.mx/ensa/ensa_tomo2.pdf
4. Cueto-Manzano AM. Peritoneal dialysis in Mexico. Kidney Int Suppl 2003; 83:S90-2.
5. United States Renal Data System. International Available at URL: www.USRDS.org
6. The Renal Association. UK Renal Registry. The Sixth Annual Report. Available at: www.renalreg.com/Front_Frame.htm [Accessed 22 December 2004]
7. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol 1988; 127:135-44.
8. Chiapella AP, Feldman HI. Renal failure among male Hispanics in the United States. Am J Public Health 1995; 85: 1001-4.
9. Su-Hernandez L, Abascal-Macias A, Mendez-Bueno FJ, Paniagua R, Amato D. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Perit Dial Int 1996; 16:362-5.
10. Amato D, Álvarez-Aguilar C, Castañeda-Limones R, Rodríguez E, Ávila-Díaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl 2005, 97:S11-17.
11. Instituto Mexicano del Seguro Social. Dirección de Prestaciones Médicas. Informe de Productividad 2006. México, DF.
12. Instituto Nacional de Estadística, Geografía e Informática (INEGI). Estadísticas por Tema. Salud. Available at: www.inegi.gob.mx
13. El IMSS en Estadísticas. 2006. Available at: www.imss.gob.mx
14. Informes Institucionales. 2006. Available at: www.imss.gob.mx
15. Arredondo A, Rangel R, de Icaza E. Costo deintervenciones para pacientes con insuficiencia renal crónica. Rev Saude Publica 1998; 32:255-61.
16. Arredondo A, Rangel R, de Icaza E. Costo-efectividad de intervenciones para insuficiencia renal crónica terminal. Rev Saude Publica 1998; 32:556-65.
17. Paniagua R, Frías Y, Ventura MJ, Rodríguez E, Hurtado ME, Alcántara G, et al. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int 2003; 23:132-7.
18. Ávila-Díaz M, Ventura MJ, Valle D, Vicenté-Martínez M, García-González Z, Cisneros C, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 2006; 26:574-80.
19. Espinosa A, Cueto-Manzano AM, Velazquez-Alva C, Hernandez A, Cruz N, Zamora B, et al. Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. Adv Perit Dial 1996; 12:302-6.
20. Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaboration Study Group. Kidney Int 1998; 54:2123-8.
21. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
22. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int 2001; 21:148-53.
23. Fabian VR, Lagunas MJ. A two-year follow-up of 265 children treated with automated peritoneal dialysis (APD) in a third-level hospital in Mexico [Abstract]. Perit Dial Int 2006; 26(Suppl 2):S102.
24. Ávila-Díaz M, Matos M, García-López E, Prado MC, Castro-Vázquez F, Ventura MJ, et al. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis treatment. Perit Dial Int 2006; 26:78-84.